Top Story

KaloBios Stock Rockets After Investment From Shkreli

Nov 24
Shares of cancer drug developer KaloBios Pharmaceuticals rocketed higher Thursday after controversial investor Martin Shkreli led a group that took a majority stake in the company just after it had decided to wind down its operations.

1 thru 10 of 7858 Stories

Kitty Power: Cats Luring Tourists Back to Brussels

FINANCE | By Maria Cheng | Dec 1
After a five-day lockdown prompted by the maximum security alert, Brussels officials are attempting to entice back tourists. Their secret weapon? Cats.

Colleges Grapple with Best Ways to Address Race Incidents

CORPORATE | By Jesse J. Holland | Dec 1
Swift action is high among the best practices that school leaders can use to help defuse campus tension, experts say.

Obama Prods World on Climate Change, Faces Pushback at Home

CORPORATE | By Nancy Benac | Dec 1
Facing pushback at home, President Barack Obama said Sunday that American leadership was helping make gains in the global fight against climate change.

How to Find the Best Cyber Monday Deals

FINANCE | Nov 30
Will the savings live up to all the hype?

In DC, Public Housing Tenants Forced Out, Then Homes Flipped

FINANCE | By Ben Nuckols | Nov 30
In the rapidly gentrifying nation's capital, real estate investors aren't the only ones flipping houses for profit. The city's public housing authority is getting in on the action - moving aging tenants out of homes and flipping them.

In Medical Marijuana States, 'Pot Doctors' Push Boundaries

LEGAL | By Carla K. Johnson | Nov 30
When it comes to oversight of boundary-pushing doctors, enforcement practices vary in the 23 states allowing medical cannabis.

Japan Ready to Submit Proposal for Australia Submarine Deal

FINANCE | By Mari Yamaguchi | Nov 29
Japan is set to bid on joint development and production of an Australian submarine, Tokyo's first major military transfer since the World War II.

Everyone Loves Same-Day Delivery, Until They Have to Pay

FINANCE | By Mae Anderson | Nov 29
Everyone likes the idea of same-day delivery. But who wants to pay for it? That's the problem merchants face as the busy holiday shopping season approaches.

Turing Reneges on Drug Price Cut, Rival's Version Sells Well

CORPORATE | By Linda A. Johnson | Nov 28
After weeks of criticism from patients, doctors and other drugmakers for hiking a life-saving medicine's price more than fifty-fold, Turing Pharmaceuticals is reneging on its pledge to cut the $750-per-pill price.

Coke Exec on 'Adversarial' Ties with Critics

CORPORATE | By Candice Choi | Nov 28
Sandy Douglas, president of Coke North America, said in an interview with The Associated Press that Coke is hoping to change its "adversarial" relationship with public health advocates.

1 thru 10 of 7858 Stories